Skip to content

CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level

Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result

UK: one in six gay men testing HIV-positive were infected recently

Penal reform, decriminalisation of illicit drugs, and increased advocacy all central to improving prisoners' health

Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV

Once-daily extended-release nevirapine works as well as twice-daily formulation

Experimental integrase inhibitor GSK-572 shows continued promise

Early treatment for infants cheaper than delaying treatment, CHER study shows

Ugandan study shows why human rights are central to HIV prevention with African men who have sex with men